BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15654977)

  • 1. Selective induction of apoptosis in melanoma cells by tyrosinase promoter-controlled CD95 ligand overexpression.
    Fecker LF; Geilen CC; Hossini AM; Schwarz C; Fechner H; Bartlett DL; Orfanos CE; Eberle J
    J Invest Dermatol; 2005 Jan; 124(1):221-8. PubMed ID: 15654977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
    Eberle J; Fecker LF; Hossini AM; Wieder T; Daniel PT; Orfanos CE; Geilen CC
    Oncogene; 2003 Dec; 22(57):9131-41. PubMed ID: 14668794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient and selective tumor cell lysis and induction of apoptosis in melanoma cells by a conditional replication-competent CD95L adenovirus.
    Fecker LF; Schmude M; Jost S; Hossini AM; Picó AH; Wang X; Schwarz C; Fechner H; Eberle J
    Exp Dermatol; 2010 Aug; 19(8):e56-66. PubMed ID: 19725869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
    Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
    Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional repression of the microphthalmia gene in melanoma cells correlates with the unresponsiveness of target genes to ectopic microphthalmia-associated transcription factor.
    Vachtenheim J; Novotna H; Ghanem G
    J Invest Dermatol; 2001 Dec; 117(6):1505-11. PubMed ID: 11886515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulation of CD95 (Fas) ligand expression in primary T cells: induction of promoter activation in CD95LP-Luc transgenic mice.
    Norian LA; Latinis KM; Eliason SL; Lyson K; Yang C; Ratliff T; Koretzky GA
    J Immunol; 2000 May; 164(9):4471-80. PubMed ID: 10779747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.
    Lillehammer T; Tveito S; Engesaeter BO; Fodstad O; Maelandsmo GM; Engebraaten O
    Cancer Gene Ther; 2005 Nov; 12(11):864-72. PubMed ID: 15891771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical mechanism of acetylsalicylic acid (Aspirin) selective toxicity toward melanoma cell lines.
    Vad NM; Yount G; Moridani MY
    Melanoma Res; 2008 Dec; 18(6):386-99. PubMed ID: 18971789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of growth of melanoma cells by CD95 (Fas/APO-1) gene transfer in vivo.
    Aragane Y; Maeda A; Cui CY; Tezuka T; Kaneda Y; Schwarz T
    J Invest Dermatol; 2000 Dec; 115(6):1008-14. PubMed ID: 11121134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a melanogenesis regulation assay system using a fluorescent protein reporter combined with the promoters for the melanogenesis-related genes in human melanoma cells.
    Lin CC; Yang CH; Lin YJ; Chiu YW; Chen CY
    Enzyme Microb Technol; 2015 Jan; 68():1-9. PubMed ID: 25435499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of microphthalmia-associated transcription factor gene expression alters skin pigmentation.
    Lin CB; Babiarz L; Liebel F; Roydon Price E; Kizoulis M; Gendimenico GJ; Fisher DE; Seiberg M
    J Invest Dermatol; 2002 Dec; 119(6):1330-40. PubMed ID: 12485436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB.
    Li-Weber M; Laur O; Dern K; Krammer PH
    Eur J Immunol; 2000 Feb; 30(2):661-70. PubMed ID: 10671224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
    Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of gene expression and protein synthesis of tyrosinase, TRP-1, lamp-1, and CD63 in UVB-induced melanogenesis in human melanomas.
    Hara H; Lee MH; Chen H; Luo D; Jimbow K
    J Invest Dermatol; 1994 Apr; 102(4):495-500. PubMed ID: 8151127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
    Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
    Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and TyrpI genes.
    Verastegui C; Bertolotto C; Bille K; Abbe P; Ortonne JP; Ballotti R
    Mol Endocrinol; 2000 Mar; 14(3):449-56. PubMed ID: 10707962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
    Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
    Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal translocation of tyrosinase and tyrosinase-related protein 1 in cutaneous melanocytes of Hermansky-Pudlak Syndrome and in melanoma cells transfected with anti-sense HPS1 cDNA.
    Sarangarajan R; Budev A; Zhao Y; Gahl WA; Boissy RE
    J Invest Dermatol; 2001 Sep; 117(3):641-6. PubMed ID: 11564171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis.
    Wagenknecht B; Roth W; Gulbins E; Wolburg H; Weller M
    Cell Death Differ; 2001 Jun; 8(6):595-602. PubMed ID: 11536010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.